Atorvastatin/candesartan cilexetil

Drug Profile

Atorvastatin/candesartan cilexetil

Alternative Names: AG 1502

Latest Information Update: 01 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ahn-Gook Pharmaceutical
  • Class Antihyperlipidaemics; Antihypertensives; Small molecules
  • Mechanism of Action Angiotensin type 1 receptor antagonists; HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Hyperlipidaemia; Hypertension

Most Recent Events

  • 01 Dec 2015 Preclinical trials in Hyperlipidaemia and Hypertension in South Korea (PO)
  • 01 Dec 2015 Ahn-Gook Pharmaceuticals plans a phase I pharmacokinetics trial in Healthy volunteers in South Korea (PO) (NCT02614352)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top